Primary imputation methods impact efficacy results in hidradenitis suppurativa clinical trials

被引：2
|
作者：
Frew, John W. [1 ]
机构：
[1] Rockefeller Univ, Lab Invest Dermatol, 1230 York Ave, New York, NY 10065 USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2020年 / 83卷 / 02期
基金：
美国国家卫生研究院;
关键词：
D O I：
10.1016/j.jaad.2020.03.078
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：663 / 665
页数：4
相关论文
共 50 条
  • [1] Update on clinical trials in hidradenitis suppurativa
    Gulliver, Wayne P.
    [J]. EXPERIMENTAL DERMATOLOGY, 2021, 30 : 67 - 68
  • [2] Investigational drugs in clinical trials for Hidradenitis Suppurativa
    Riis, Peter Theut
    Thorlacius, Linnea R.
    Jemec, Gregor B.
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2018, 27 (01) : 43 - 53
  • [3] Ethnoracial representation in hidradenitis suppurativa clinical trials
    Kareem G. Elhage
    Mitchell S. Davis
    Marwa Hakimi
    Riley K. Spencer
    Joy Q. Jin
    Samuel Yeroushalmi
    Mimi Chung
    Erin Bartholomew
    Tina Bhutani
    Wilson Liao
    [J]. Archives of Dermatological Research, 2023, 315 : 1793 - 1796
  • [4] Ethnoracial representation in hidradenitis suppurativa clinical trials
    Elhage, Kareem G.
    Davis, Mitchell S.
    Hakimi, Marwa
    Spencer, Riley K.
    Jin, Joy Q.
    Yeroushalmi, Samuel
    Chung, Mimi
    Bartholomew, Erin
    Bhutani, Tina
    Liao, Wilson
    [J]. ARCHIVES OF DERMATOLOGICAL RESEARCH, 2023, 315 (06) : 1793 - 1796
  • [5] Demographic and Therapeutic Trends in Clinical Trials for Hidradenitis Suppurativa
    Mulligan, Kathleen
    O'Connell, Katie
    Ahmad, Areebah
    Kim, Lori
    Coleman, Madeline
    da Silva, Alexandra
    Dellavalle, Robert
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB32 - AB32
  • [6] Clinical Trials and Skin of Color: The Example of Hidradenitis Suppurativa
    Okeke, Chidubem A., V
    Perry, Jessica D.
    Simmonds, Faith C.
    Erskine, Azure B.
    Shipman, William D.
    Seltzer, Janyla A.
    Andrews, Marcus R.
    Saini, Arjun D.
    Cole, Taylor A.
    Perkins, Jamilah A.
    Otado, Jane
    Kwagyan, John
    Collins, Cassandra I. F.
    Okoye, Ginette A.
    Byrd, Angel S.
    [J]. DERMATOLOGY, 2022, 238 (01) : 180 - 184
  • [7] Psychosocial impact of clinical severity on hidradenitis suppurativa
    Jfri, A.
    Litvinov, I.
    Netchiporouk, E.
    O'Brien, E.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (09) : B15 - B15
  • [8] A novel hidradenitis suppurativa efficacy variable, HiSCR (hidradenitis suppurativa clinical response), is responsive to change with adalimumab therapy: Results of a phase II study
    Kimball, Alexandra B.
    Williams, David A.
    Jemec, Gregor B. E.
    Gu, Yihua
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2013, 68 (04) : AB40 - AB40
  • [9] Hidradenitis suppurativa: Clinical characteristics and determinants of treatment efficacy
    Vural, Secil
    Gundogdu, Mustafa
    Akay, Bengu N.
    Boyvat, Ayse
    Erdem, Cengizhan
    Kocyigit, Pelin
    Bostanci, Seher
    Sanli, Hatice
    Kundakci, Nihal
    [J]. DERMATOLOGIC THERAPY, 2019, 32 (05)
  • [10] A review of the placebo rates of response in clinical trials of hidradenitis suppurativa
    McCarthy, S.
    Sheehan, D.
    Murphy, M.
    Shanahan, F.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2016, 175 : 75 - 75
12345